Navigation Links
The Michigan Life Sciences Pipeline Announces 'The Funding Place(TM)' and Other Resources to Connect Investors and Startups
Date:10/8/2008

TROY, Mich., Oct. 8 /PRNewswire/ -- CJPS Enterprises, LLC (http://www.CJPS-Enterprises.com), the operator of the Michigan Life Sciences Pipeline (http://www.MichiganPipeline.com) is announcing a new service available to Michigan companies looking for funding for their business, or looking to invest in Michigan companies involved in healthcare.

Some of the existing resources available on the Michigan Life Sciences Pipeline's website include databases of Michigan-based funding sources, economic development organizations, and SmartZones(TM), which are great sources of assistance for small or growing businesses. In addition to these, the firm has just added three additional ways for potential investors to connect with these companies in pursuit of financing:

1. The Funding Place(TM): Michigan Life Sciences Platinum and Diamond Members can now list a description of their venture by attaching non-confidential documents to their listings, and their funding requirements such as the type of financing, the timing, and the amount sought. Investors can view these listings and contact the companies directly.

2. Solicitation letter: CJPS Enterprises, the operator of the Michigan Life Sciences Pipeline, can leverage its network to introduce investment opportunities to wealthy Michiganders with large liquid net worth, by sending them a solicitation letter including the information from the company looking for financing.

3. Email blast: CJPS Enterprises can also send emails describing particular opportunities to potential investors nationwide, such as venture capitalists, and local companies involved in healthcare, on the companies' behalf.

The Michigan Life Sciences Pipeline is the 21st Century Jobs Fund initiative designed to facilitate and accelerate growth in the healthcare industry in Michigan. For more information, contact The Michigan Life Sciences Pipeline at Info@MichiganPipeline.com, or visit http://www.michiganpipeline.com .

CJPS Enterprises, LLC is a global hands-on consulting firm that specializes in facilitating breakthrough growth for healthcare companies through entrepreneurial leadership, strategy development and plan execution. The firm leverages its deep expertise in intellectual property management, unique industry Rolodex(R), and experience in setting up powerful strategic alliances and innovative business development approach to generate very rapid and sustainable growth. For more information, please visit http://www.CJPS-Enterprises.com .

Contact: Stacey Neir

Stacey@MichiganPipeline.com

Phone: 1.248.593.1264


'/>"/>
SOURCE CJPS Enterprises, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. New Report on 633 Biotechnology Medicines Under Development Released in Michigan
2. The Michigan Life Sciences Pipeline Announces New Best Practices Seminars Tailored to Michigan Businesses
3. Michigan Innovation Equipment Depot Launches Next Phase of Distribution
4. The Michigan Life Sciences Pipeline Adds More Resources On Its Website
5. Michigan Tech scientist models molecular switch
6. Ash Stevens Inc. Named One of Michigan 50 Companies to Watch
7. Beaumont Hospitals in Michigan Selects Halogen Software for Pay for Performance System
8. Lambert, Edwards & Associates Named Agency of Record for The West Michigan Science & Technology Initiative
9. West Michigan Science & Technology Initiative Seeks Exhibitors for Annual Life Science Showcase
10. Ann Arbor SPARK Receives $3.75M from Michigans Company Formation & Growth Fund
11. Michigan Life Science Network: Virtual Companies Get Global Reception
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , Dec. 2, 2016 Amgen (NASDAQ: ... ) today announced the submission of a Marketing Authorization Application ... a biosimilar candidate to Avastin ® (bevacizumab). The companies ... to the EMA. "The submission of ABP ... seeks to expand our oncology portfolio," said Sean E. ...
(Date:12/2/2016)... ... , ... ACEA Biosciences, Inc. announced today that it will be presenting updated ... World Conference on Lung Cancer 2016, taking place in Vienna, Austria December 3rd-8th. ... for AC0010 in patients with advanced non-small cell lung cancer harboring the EGFR T790M ...
(Date:12/2/2016)... ... December 01, 2016 , ... ... (CSS) and the popularity of US Single Day Events (SDE) to organize a ... Summer 2018, in Raleigh, NC. Topics of the pharmaceutical and life sciences industry ...
(Date:12/2/2016)... IL (PRWEB) , ... December 01, 2016 , ... ... to congratulate long-term client Nanowear on their recent FDA Class II 510(k) clearance ... cleared a significant hurdle in commercializing remote cardiac monitoring devices that rely on ...
Breaking Biology Technology:
(Date:11/22/2016)... Minn. , Nov. 22, 2016   MedNet ... supports the entire spectrum of clinical research, is pleased ... Medical LiveWire Healthcare and Life Sciences Awards ... award caps off an unprecedented year of recognition and ... trials for over 15 years. iMedNet ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Public Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is ... analysis for Private Biobanks shows the highest Compounded Annual Growth ... region during the analysis period 2014-2020. ... CAGR of 9.95% followed by Europe ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, ... developing therapeutics focused on the gut microbiome, today ... of 25,000,000 shares of its common stock and ... stock at a price to the public of ... to Synthetic Biologics from the offering, excluding the ...
Breaking Biology News(10 mins):